Pradaxa Ranked Highest in Side Effects As Lawsuits Move to Federal Court

Share Article

The Pradaxa Resource Center is the Web’s largest source for information on Pradaxa research, side effects and legal news. Visit http://www.Pradaxa-lawsuits.org

Pradaxa lawsuit
Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.

The patient advocates at the Pradaxa Resource Center are alerting those who have been prescribed the blood thinner Pradaxa that the drug has been associated with severe internal bleeding. A judicial panel has now consolidated lawsuits from those affected to a central federal court, which will expedite litigation for victims.

Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular blood thinning drug prescribed to prevent strokes and blood clots in patients with atrial fibrillation. Although only on the market since October, 2010, Pradaxa sold over $1 billion for the year ending February, 2012, according to a Wall Street Journal report on April 24, 2012.

On December 7, 2011, however, the FDA warned that it would launch an investigation after receiving more injury or death reports from Pradaxa than expected. This came after Reuters reported in November that German drug maker Boehringer Ingelheim admitted receiving more than 260 reports of internal bleeding death among users.

Recently, the Institute for Safe Medication Practices reported on June 6, 2012 that Pradaxa led all other medications in 2011 for reports of death or bleeding to the FDA.

Due to the number of lawsuits expected over Pradaxa bleeding injury or death, the United States Judicial Panel on Multidistrict Litigation (JPML) issued an order on August 8, 2012 consolidating Pradaxa lawsuits to the Southern District of Illinois. The case is known as MDL No. 2385 IN RE: Pradaxa Product Liability Litigation.

On July 25th, Judge David Herndon, who will oversee the litigation, issued an order denying attempts by Boehringer Ingelheim to dismiss the Pradaxa bleeding lawsuits.

The Pradaxa Resource Center believes moving the individual Pradaxa lawsuits to one federal court will be more beneficial than a Pradaxa class action lawsuit. However, due to the specialized nature of these federal MDL cases, victims should make sure any lawyer they choose has experience in this type of litigation.

Those affected by a Pradaxa injury are urged to speak with a lawyer about their legal options. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, Pradaxa side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ryan Mayer
Visit website